An oncolytic adenovirus enhanced for Toll-like receptor 9 stimulation increases anti-tumor immune responses and reduces myeloid-derived suppressor cell activity

被引：0
|
作者：
Cerullo, V. [1 ]
Diaconu, I. [1 ]
Vaha-Koskela, M. [1 ]
Romano, V. [1 ]
Ugolini, M. [1 ]
Rouvinen-Lagerstrom, N. [1 ]
Escutenaire, S. [1 ]
Holm, S-L [1 ]
Pesonen, S. [1 ]
Vile, R. [2 ]
Kanerva, A. [1 ]
Hemminki, A. [1 ]
机构：
[1] Univ Helsinki, Canc Gene Therapy Grp, FIN-00290 Helsinki, Finland
[2] Mayo Clin, Dept Immunol, Rochester, MN USA
来源：
HUMAN GENE THERAPY | 2011年 / 22卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A84 / A84
页数：1
相关论文
共 50 条
  • [21] Glioma-infiltrating myeloid derived suppressor cells inhibit anti-tumor T cell responses
    Kamran, Neha
    Assi, Hikmat
    Candolfi, Marianela
    Moreno, Mariela
    Li, Youping
    Lowenstein, Pedro R.
    Castro, Maria G.
    CANCER RESEARCH, 2014, 74 (19)
  • [22] Synergistic Anti-Tumor Efficacy of Toll-like Receptor and CD40 Stimulation with an Immunogenic Neoantigen Vaccine
    Hoki, T.
    Yamauchi, T.
    Eppolito, C.
    Francois, A. J.
    Odunsi, K.
    Ito, F.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S148 - S148
  • [23] Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma
    Kim, Sun Hye
    Li, Man
    Trousil, Sebastian
    Zhang, Yaqing
    di Magliano, Marina Pasca
    Swanson, Kenneth D.
    Zheng, Bin
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (08) : 1740 - 1748
  • [24] Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4
    Llitjos, Jean-Franois
    Auffray, Cedric
    Alby-Laurent, Fanny
    Rousseau, Christophe
    Merdji, Hamid
    Bonilla, Nelly
    Toubiana, Julie
    Belaidouni, Nadia
    Mira, Jean-Paul
    Lucas, Bruno
    Chiche, Jean-Daniel
    Pene, Frederic
    JOURNAL OF PATHOLOGY, 2016, 239 (04): : 473 - 483
  • [25] Neutrophil-like Myeloid Derived Suppressor Cells are Increased in Heavy Tumor Burden and Upregulate MHC Class II Expression in Response to Toll-like Receptor Stimulation
    Tseng, Willican W.
    Engleman, Edgar G.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 949 - 950
  • [26] Anti-tumor applications of activating toll-like receptor 9 with PF-3512676 (formerly CPG 7909)
    Krieg, Arthur M.
    EJC SUPPLEMENTS, 2006, 4 (06): : 15 - 15
  • [27] Targeting myeloid-derived suppressor cells in combination with tumor cell vaccination predicts anti-tumor immunity and breast cancer dormancy: an in silico experiment
    Mehdizadeh, Reza
    Shariatpanahi, Seyed Peyman
    Goliaei, Bahram
    Rueegg, Curzio
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [28] The Number of Toll-Like Receptor 9-Agonist Motifs in the Adenovirus Genome Correlates with Induction of Dendritic Cell Maturation by Adenovirus Immune Complexes
    Perreau, Matthieu
    Welles, Hugh C.
    Pellaton, Celine
    Gjoksi, Bebeka
    Potin, Lambert
    Martin, Ricardo
    Harari, Alexandre
    Bett, Andrew
    Casimiro, Danilo
    Gall, Jason
    Barouch, Dan H.
    Kremer, Eric J.
    Pantaleo, Giuseppe
    JOURNAL OF VIROLOGY, 2012, 86 (11) : 6279 - 6285
  • [29] Targeting myeloid-derived suppressor cells in combination with tumor cell vaccination predicts anti-tumor immunity and breast cancer dormancy: an in silico experiment
    Reza Mehdizadeh
    Seyed Peyman Shariatpanahi
    Bahram Goliaei
    Curzio Rüegg
    Scientific Reports, 13
  • [30] Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses
    Sumida, Kentaro
    Wakita, Daiko
    Narita, Yoshinori
    Masuko, Kazutaka
    Terada, Satoshi
    Watanabe, Kazue
    Satoh, Takayuki
    Kitamura, Hidemitsu
    Nishimura, Takashi
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (08) : 2060 - 2072
12345